Literature DB >> 20144488

Glucose control in patients with type 2 diabetes based on frequency of insulin glargine administration.

Audrey K Housel1, Robert F Shaw, Nancee V Waterbury.   

Abstract

Glucose control and predictors of a switch from once to twice daily administration of insulin glargine in patients with type 2 diabetes was investigated. A mean decrease in %A1c of 0.52+/-0.12 (p=0.14) resulted, indicating clinical relevance. Daily dose was the only significant predictor of twice daily therapy. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20144488     DOI: 10.1016/j.diabres.2010.01.020

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  1 in total

1.  Is insulin degludec a more effective treatment for patients using high doses of insulin glargine but not attaining euglycemia? Some case reports from India.

Authors:  Binayak Sinha; Kalyan Kumar Gangopadhyay; Samit Ghosal
Journal:  Diabetes Metab Syndr Obes       Date:  2014-06-23       Impact factor: 3.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.